125 related articles for article (PubMed ID: 14733758)
1. Lifetime costs of colon and rectal cancer management in Canada.
Maroun J; Ng E; Berthelot JM; Le Petit C; Dahrouge S; Flanagan WM; Walker H; Evans WK
Chronic Dis Can; 2003; 24(4):91-101. PubMed ID: 14733758
[TBL] [Abstract][Full Text] [Related]
2. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
3. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
Delcò F; Egger R; Bauerfeind P; Beglinger C
Aliment Pharmacol Ther; 2005 Mar; 21(5):615-22. PubMed ID: 15740546
[TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary treatment of colorectal cancer in New Zealand: survival rates from 1997-2002.
Keating J; Yong D; Cutler G; Johnston J
N Z Med J; 2006 Sep; 119(1242):U2238. PubMed ID: 16998579
[TBL] [Abstract][Full Text] [Related]
5. Estimates of the lifetime direct costs of treatment for metastatic breast cancer.
Berkowitz N; Gupta S; Silberman G
Value Health; 2000; 3(1):23-30. PubMed ID: 16464178
[TBL] [Abstract][Full Text] [Related]
6. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
[TBL] [Abstract][Full Text] [Related]
7. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
Ramsey SD; Berry K; Etzioni R
Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
Barton MB; Gabriel GS; Miles S
ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
[TBL] [Abstract][Full Text] [Related]
9. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
11. Estimates of the lifetime costs of breast cancer treatment in Canada.
Will BP; Berthelot JM; Le Petit C; Tomiak EM; Verma S; Evans WK
Eur J Cancer; 2000 Apr; 36(6):724-35. PubMed ID: 10762744
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
14. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
Rulyak SJ; Lieberman DA; Wagner EH; Mandelson MT
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):470-6; quiz 407. PubMed ID: 17270502
[TBL] [Abstract][Full Text] [Related]
15. Metastatic non-small cell lung cancer: costs associated with disease progression.
Fox KM; Brooks JM; Kim J
Am J Manag Care; 2008 Sep; 14(9):565-71. PubMed ID: 18778171
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J
Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis in colorectal cancer using a semi-Markov model.
Castelli C; Combescure C; Foucher Y; Daures JP
Stat Med; 2007 Dec; 26(30):5557-71. PubMed ID: 18058847
[TBL] [Abstract][Full Text] [Related]
18. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
19. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
Poon I; Pintilie M; Potvin M; McGowan T
Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
[TBL] [Abstract][Full Text] [Related]
20. [Economic aspects of oncologic surgery: what do we know, are they relevant; must--may--we regard them?].
Nagel E; Meyer zu Vilsendorf A; Obermann K
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():91-7. PubMed ID: 9102021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
